Contemplating the Future of List Prices
What execs and experts think of the future of drug costs.
FDA, FTC Issue More CBD Manufacturer Warnings
Fifth company warned about unsubstantiated claims this year.
FDA Approves Biophen for Hypotension in Anesthesia Settings
New formulation improves safety for patients.
New Drug Review: Tafamidis Meglumine for Cardiomyopathy
Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
FDA Approves Mealtime Insulin for Use with Infusion Pumps
Previously approved for IV infusion.
Ustekinumab Gains FDA Approval as Ulcerative Colitis Treatment
Fourth indication expansion for the 2009 drug.
Life-Altering Gene Therapy Pipeline Poses Challenges
What to expect for these high-dollar drugs.
FDA Approves Triple Combination Therapy for Cystic Fibrosis
Drug able to treat 18,000 people will cost over $300k per year.
Solving the Drug Shortage Burden
Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.
4 Facts Pharmacists Need to Know About Cancer Rates
A look at incidence rates, survival rates, and more.
Minocycline Topical Foam 4% Approved by FDA for Acne Vulgaris
Available for prescribing starting January 2020
FDA Approves Baloxavir Marboxil for High-Risk Flu Patients
First approved in 2018 for patients 12 years of age and older.
Providing Healthcare to Transgender Patients
Education can help pharmacists feel more comfortable dispensing care.
Cetirizine IV Approved for Pediatric Acute Urticaria
Originally approved in 1995 for use in adults only.
New Data Show Pharmacy Salaries Remain Healthy
Job growth may stagnate and retail jobs continue to dwindle.
Tuberculosis Vaccine May Reduce Lung Cancer Risk
Results of multi-generational study indicates risk reduction potential.
U.S. Adults Forgoing Flu Shot
Study shows that efficacy is a major concern.
State Laws May Determine Access to Pharmacy-based PrEP Clinics
What new laws could mean for pharmacies’ role in combatting HIV.
Independents Prepare to Close Up Shop
Many cite PBM fees as the primary cause in NCPA survey.
Official CVS/Aetna Merger: Greater Convenience, Less Cost Reform
The deal is now official, but the companies have been acting as one for some time.
Top 10 Best States to Be a Pharmacist in 2019
Where pharmacists should be looking to live.
FDA Approves Asenapine for Schizophrenia
Administered via a once-daily transdermal patch.
CDC: Pregnant Women Not Getting Important Vaccines
Mothers and babies need the influenza and whooping cough vaccines, CDC says.
Alternative Approaches to Opioids
New and old non-opioid pain management solutions.
FDA Approves Lasmiditan for Adult Migraines
Currently under DEA review.
5 Types of Diabetes Patients Who Need More Management
Tips for identifying patients with diabetes who need more direction and help.
5 New Diabetes Technologies and Treatments
Noteworthy diabetes management products and updates making waves this year.
Chains Implementing Tech to Help Track Opioid Misuse
Patients at-risk for substance abuse more easily identified and managed.
FDA Warns of Cough Syrup Contamination
Consumers should stop use and report any adverse events.
Lupus and Celiac Disease: What Pharmacists Need to Know
How to help manage two of the most common autoimmune diseases.
